(Q33856502)

29 July 2017

title

Pleural space perfusion with cisplatin in the multimodality treatment of malignant mesothelioma: a feasibility and pharmacokinetic study (English)

1 reference

29 July 2017

1 reference

1 reference

Ratto GB

1

1 reference

29 July 2017

Civalleri D

2

1 reference

29 July 2017

Esposito M

3

1 reference

29 July 2017

Spessa E

4

1 reference

29 July 2017

Alloisio A

5

1 reference

29 July 2017

De Cian F

6

1 reference

29 July 2017

Vannozzi MO

7

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 April 1999

1 reference

The Journal of Thoracic and Cardiovascular Surgery

29 July 2017

published in

1 reference

29 July 2017

volume

117

1 reference

29 July 2017

issue

4

1 reference

29 July 2017

page(s)

759-765

1 reference

Multimodality therapy for malignant pleural mesothelioma

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970297-7

Pleurectomy/decortication and adjuvant therapy for malignant mesothelioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970297-7

Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970297-7

Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970297-7

Pharmacokinetics of cisplatin instilled into the pleural cavity following panpleuropneumonectomy in patients with malignant pleurisy due to lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970297-7

High doses of intrapleural cisplatin in a case of malignant pleural mesothelioma. Clinical observations and pharmacokinetic analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970297-7

Intrapleural perfusion hyperthermo-chemotherapy for malignant pleural dissemination and effusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970297-7

A new device for the treatment of pleural malignancies: intrapleural chemohyperthermia preliminary report.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970297-7

Clinical features and current treatment of diffuse malignant pleural mesothelioma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970297-7

Surgically debulked malignant pleural mesothelioma: results and prognostic factors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970297-7

Extrapleural pneumonectomy in the setting of a multimodality approach to malignant mesothelioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970297-7

Isolated lung perfusion with platinum in the treatment of pulmonary metastases from soft tissue sarcomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970297-7

Intrapleural cisplatin and cytarabine in the management of malignant pleural effusions: a Lung Cancer Study Group trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970297-7

Patterns of failure after trimodality therapy for malignant pleural mesothelioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970297-7

Surgery followed by intracavitary plus systemic chemotherapy in malignant pleural mesothelioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970297-7

Intrapleural chemotherapy for patients with incompletely resected malignant mesothelioma: the UCLA experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970297-7

Response of peritoneal solid tumours after intraperitoneal chemohyperthermia treatment with cisplatin or carboplatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970297-7

Interaction of cis-diamminedichloro-platinum(II) and its analogues cis-1,1- cyclobutanedicarboxylato(2R)-2-methyl-1,4-butanediammineplatinum(II) and cis-diammine(glycolato)platinum with hyperthermia in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970297-7

In vitro effect of hyperthermia on chemoenhancement and uptake of cisplatin in human pharyngeal carcinoma KB cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970297-7

Thermochemotherapy for melanoma metastases in liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970297-7

Abdomino-pelvic hyperthermia and intraperitoneal carboplatin in epithelial ovarian cancer: feasibility, tolerance and pharmacology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970297-7

Chemotherapy in malignant pleural mesothelioma. A review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2899%2970297-7

10.1016/S0022-5223(99)70297-7

7 January 2021

Identifiers

DOI

1 reference

29 July 2017

1 reference